Featured news in The Life Sciences Report



Cesca Therapeutics Inc. (KOOL:NASDAQ)
Cesca Therapeutics to Announce Second Quarter Fiscal 2016 Results and Provide a Status Update to Investors on February 16, 2016 (2/11/2016)

view
 


StemCells Inc. ()
STANLIB Multi-Manager Medium Equity Fund of Funds A reaches new 52-Week Low (2/11/2016)

view
 


Celgene Corp. (CELG:NASDAQ)
Actelion (ALIOF) Misses Q4 Earnings, Revenue Estimates (2/10/2016)

view
 

Celgene Corp. (CELG:NASDAQ)
INSYS (INSY) Initiates Phase II Study for Infantile Spasms (2/10/2016)

view
 


Amarantus BioScience Holdings Inc. (AMBS:OTCQB)
Amarantus BioScience Holdings, Inc., (OTCBB: AMBS) Has Received Orphan Drug Designation from the US FDA (2/11/2016)

view
 


Innovation Pharmaceuticals (Formerly known as Cellceutix Corp.) (IPIX:OTC)
Cellceutix Meets With FDA for Phase 2 Clinical Trial of Kevetrin for Ovarian Cancer (2/10/2016)

view
 


Regeneus Ltd. (RGS:ASX)
Reports Progenza stem cell therapy clears initial safety review (0/0/0000)

view
 


Athersys Inc. ()
Athersys' MultiStem® Data to be Presented at International Stroke Conference 2016 (2/10/2016)

view
 

Athersys Inc. ()
Athersys to Host Year End 2015 Financial Results Call (2/9/2016)

view
 


CorMedix Inc. (CRMD:NYSE.MKT)
CorMedix Proprietary Antimicrobial Technology to be Featured at 14th Annual South Beach Symposium (2/10/2016)

view
 


Inovio Pharmaceuticals Inc. (INO:NASDAQ)
These Two Companies Are Working On The Zika Virus Cure (2/9/2016)

view
 


Celgene Corp. (CELG:NASDAQ)
Regeneron Q4 Earnings Lag, Gives 2016 View for Eylea Sales (2/9/2016)

view
 

Celgene Corp. (CELG:NASDAQ)
Epizyme's Tazemetostat Gets Orphan Drug Status in the U.S. (2/9/2016)

view
 

Celgene Corp. (CELG:NASDAQ)
Biotech ETFs Slide as Stocks Report Mixed Q4 Results (2/9/2016)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Announces Release Date For 2015 Full Year Results (2/10/2016)

view
 


Amarantus BioScience Holdings Inc. (AMBS:OTCQB)
Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia (2/10/2016)

view
 

Amarantus BioScience Holdings Inc. (AMBS:OTCQB)
Amarantus to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference (2/9/2016)

view
 


Cesca Therapeutics Inc. (KOOL:NASDAQ)
Texas Stem Cell Enters Into an Agreement With Cesca Therapeutics for Use of AutoXpress® Technology for Cord Blood Processing (2/9/2016)

view
 


RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB)
RepliCel Life Sciences Announces Warrant Exercise Incentive Program (2/9/2016)

view
 


Nobilis Health Corp. ()
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Nobilis Health Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 21, 2016 - HLTH (2/8/2016)

view
 


Inovio Pharmaceuticals Inc. (INO:NASDAQ)
Inovio Pharmaceuticals Inc. (NASDAQ: INO) Working on a Zika Vaccine (2/9/2016)

view
 


Cipher Pharmaceuticals Inc. (CPHR:NASDAQ; CPH:TSX)
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call (2/9/2016)

view
 


Innovation Pharmaceuticals (Formerly known as Cellceutix Corp.) (IPIX:OTC)
Cellceutix to Submit Special Protocol Assessment Request to FDA for Phase 3 Clinical Study of Antibiotic Brilacidin for ABSSSI (2/9/2016)

view